biblio

Export 11 results:
Filters: Keyword is Antitubercular activity and Author is Sarkar, Dhiman  [Clear All Filters]
2013
R. A. Limaye, Kumbhar, V. B., Natu, A. D., Paradkar, M. V., Honmore, V. S., Chauhan, R. R., Gample, S. P., and Sarkar, D., “One pot solvent free synthesis and in vitro antitubercular screening of 3-aracylphthalides against mycobacterium tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 3, pp. 711-714, 2013.
2015
R. R. Joshi, Barchha, A., Khedkar, V. M., Pissurlenkar, R. R. S., Sarkar, S., Sarkar, D., Joshi, R. R., Joshi, R. A., Shah, A. K., and Coutinho, E. C., “Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold”, Chemical Biology & Drug Design, vol. 85, no. 2, pp. 201-207, 2015.
2016
S. T. Dhumal, Deshmukh, A. R., Bhosle, M. R., Khedkar, V. M., Nawale, L. U., Sarkar, D., and Mane, R. A., “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
N. C. Desai, Somani, H., Trivedi, A., Bhatt, K., Nawale, L., Khedkar, V. M., Jha, P. C., and Sarkar, D., “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
2018
V. Shinde, Mahulikar, P., Mhaske, P. C., Nawale, L., and Sarkar, D., “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
A. B. Danne, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
2019
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
V. Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
A. P. Chavan, Deshpande, R. R., Borade, N. A., Shinde, A., Mhaske, P. C., Sarkar, D., and Bobade, V. D., “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
2022
N. C. Desai, Bhatt, K., Jadeja, D. J., Mehta, H. K., Khedkar, V. M., and Sarkar, D., “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.